Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
INOVIO PHARMACEUTICALS, INC. issued up to 13,564,268 shares of warrant for exercise price of $1.75 per share.
- Security
- warrant
- Shares
- up to 13,564,268 shares
- Consideration
- exercise price of $1.75 per share
Exact text from the filing
each representing the right to purchase one share of Common Stock at an exercise price of $0.001 (the “Pre-Funded Warrants”) in lieu thereof), and have an exercise price of $1.75 per share (or $1.749 per Pre-Funded Warrant) and would otherwise have expired at 5:00 p.m. New York City time on January 28, 2026, which is 30 days following the Company’s public
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
INOVIO PHARMACEUTICALS, INC. amended Series A Warrants (effective 2026-01-27).
- Action
- amendment
- Effective
- 2026-01-27
Exact text from the filing
On January 27, 2026, Inovio Pharmaceuticals, Inc. (the “Company”) amended each of its outstanding Series A warrants issued on July 7, 2025 (the “Series A Warrants”) to extend the expiration date
View on SEC.gov